Editorials

• High bleeding risk patients undergoing percutaneous coronary intervention: still a large margin left for improvement

  Juan M. Ruiz-Nodar

  Rev Esp Cardiol. 2020;73:521-3

• Critical care networks for the treatment of cardiogenic shock. Where and how should the shock code be implemented?

  Aitor Uribarri, José A. San Román

  Rev Esp Cardiol. 2020;73:524-6

• Exercising in times of COVID-19: what do experts recommend doing within four walls?

  Miguel Ángel Rodríguez, Irene Crespo, Hugo Olmedillas

  Rev Esp Cardiol. 2020;73:527-9

• Comments on the 2019 ESC guidelines on supraventricular tachycardia

  SEC Working Group for the 2019 ESC guidelines on supraventricular tachycardia, Expert Reviewers for the 2019 ESC guidelines on supraventricular tachycardia, SEC Guidelines CommitteeSEC Working Group for the 2019 ESC guidelines on supraventricular tachycardiaExpert Reviewers for the 2019 ESC guidelines on supraventricular tachycardiaSEC Guidelines Committee

  Rev Esp Cardiol. 2020;73:445-51

• Comments on the 2019 ESC guidelines on acute pulmonary embolism

  SEC Working Group for the 2019 ESC guidelines on acute pulmonary embolism, Expert Reviewers for the 2019 ESC on acute pulmonary embolism, SEC Guidelines Committee

  Rev Esp Cardiol. 2020;73:452-6

• Comments on the 2019 ESC guidelines on chronic coronary syndromes

  SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes, Expert Reviewers for the 2019 ESC guidelines on chronic coronary syndromes, SEC Guidelines CommitteSEC Working Group for the 2019 ESC guidelines on chronic coronary syndromesSEC Guidelines Committee

  Rev Esp Cardiol. 2020;73:439-44

• Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?

  David Dobarro, Aida Ribera-Solé

  Rev Esp Cardiol. 2020;73:345-7

• Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias

  SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines CommitteGrupo de Trabajo de la SEC para la guía ESC 2019 sobre el tratamiento de las dislipemiasRevisores expertos para la ESC 2019 sobre el tratamiento de las dislipemiasComité de Guías de la SEC

  Rev Esp Cardiol. 2020;73:348-53

• Comments on the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular disease

  Joint Working Group of the SEC and SEEN for the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseases, Expert Reviewers for the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseases, and the SEC Guidelines Committee, Joint Working Group of the Spanish Society of Cardiology and Spanish Society of Endocrinology and Nutrition on the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseasesSpanish Society of CardiologySpanish Society of Endocrinology and NutritionExpert reviewers for the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseasesSEC Guidelines Committee

  Rev Esp Cardiol. 2020;73:354-60

• Are we on the right track to reduce childhood obesity?

  Gloria Santos-Beneit, María Dolores Marrodán Serrano

  Rev Esp Cardiol. 2020;73:277-9

• Leadless cardiac pacing in the elderly: less is more

  Sergio Richter

  Rev Esp Cardiol. 2020;73:280-1

• Social inequalities in cardiovascular mortality in Spain: differences by age and gender and implications for prevention

  Irene R. Dégano

  Rev Esp Cardiol. 2020;73:275-6

• Closure of patent foramen ovale in cryptogenic stroke: also in patients older than 60 years?

  Jaime Masjuan, Sebastián García-Madrona, Alicia de Felipe

  Rev Esp Cardiol. 2020;73:197-9

• Novel strategies to evaluate the effectiveness of heart failure services

  William J. McKenna, María Nieves Montoro-López

  Rev Esp Cardiol. 2020;73:200-4

• Primordial prevention: paramount in cardiovascular prevention

  José María Castellano Vázquez, Juan Miguel Fernández Alvira, Valentín Fuster

  Rev Esp Cardiol. 2020;73:194-6

• Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome

  Umair Khalid, Hani Jneid, Anita Deswal

  Rev Esp Cardiol. 2020;73:104-6

• Repaired isolated pulmonary valve stenosis: living happily ever after?

  Heleen B. van der Zwaan, Bart W. Driesen, Folkert J. Meijboom

  Rev Esp Cardiol. 2020;73:107-9

• Percutaneous management of paravalvular leaks: an alternative to surgery or first-line therapy

  Xavier Millán, Chi-Hion Li, Dabit Arzamendi

  Rev Esp Cardiol. 2020;73:110-3

• Invasive management in acute non–ST-segment elevation coronary syndromes: be quick or be dead?

  Marcelo Sanmartín Fernández, María Abellás Sequeiros

  Rev Esp Cardiol. 2020;73:8-10

• Arterial stiffness and reference values

  José R. Banegas, Raymond R. Townsend

  Rev Esp Cardiol. 2020;73:11-3